Baseline Practice and Patient Characteristics in the ADDITION-Cambridge Screening Trial; Data are Median (Inter-quartile Range) Unless Otherwise Indicated
| Screening Group | No-Screening Control Groupa | |
|---|---|---|
| Practices | n = 27 | n = 5 |
| Practice list size | 6,610 (5,144–9,966) | 8,827 (8,694–10,986) |
| Crude prevalence of diabetes, % | 2.9 (2.5–3.5) | 3.2 (3.0–3.4) |
| Physician full-time equivalents | 3.5 (2.5–5.0) | 4.5 (4.0–5.0) |
| Index of Multiple Deprivation scoreb | 11.7 (6.9–11.6) | 15.7 (9.1–15.7) |
| Participants | n = 1,373 | n = 572 |
| Age, years | 60 (54–65) | 60 (54–65) |
| Men, n (%) | 839 (61.1) | 360 (62.9) |
| BMI, kg/m2 | 29.4 (27.7–32.3) | 29.6 (27.8–32.2) |
| Cambridge diabetes risk score | 0.36 (0.25–0.52) | 0.38 (0.25–0.56) |
| Prescribed anti-hypertensive medication, n (%) | 654 (47.6) | 298 (52.1) |
| Prescribed steroids, n (%) | 68 (5.0) | 17 (3.0) |
BMI = body mass index.
↵a There were no statistically significant differences between groups.
↵b The Index of Multiple Deprivation combines a number of indicators, chosen to cover a range of economic, social and housing issues, into a single deprivation score for each small area in England. This allows each area to be ranked relative to one another according to their level of deprivation. A high Index of Multiple Deprivation score indicates a high level of deprivation.